DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
| SUNZEN BIOTECH BERHAD |
| Subject | Dealings Outside Closed Period |
| No | Salutation | Name | Designation | Description Of "Others" Designation |
MR |
PHANG TONG ENG |
Chief Financial Officer |
||
| Type of Transaction | Acquired | |||
| Description of "Others" Type of Transaction | ||||
| Date of Transaction | 17 Jan 2024 | |||
| Description of Securities |
Ordinary Shares |
|||
| No of Securities Transacted | 200,000 | |||
| % of Securities Transacted | 0.028 | |||
| Consideration | Malaysian Ringgit (MYR) 0.262 | |||
Announcement Info
| Company Name | SUNZEN BIOTECH BERHAD |
| Stock Name | SUNZEN |
| Date Announced | 22 Jan 2024 |
| Category | Dealings in Listed Securities (Chapter 14 of Listing Requirements) |
| Reference Number | DLR-19012024-00033 |